Based on our observations that Stat5a but not Stat5b mRNA levels correlated with breast cancer outcome and that Stat5a protein is selectively reduced over breast cancer progression, we evaluated Stat5a protein levels with immunohistochemistry in formalin-fixed, paraffin-embedded archival breast tumor tissues with clinical outcome. This evidence concerns the gene STAT5A and breast neoplasm.